Eli Lilly

IRS: 350470950
LLY
Eli Lilly

Eli Lilly is a drug company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiantfor immunology.

Founded
1901 (120 years)
Investor RelationsSEC
Revenue
25 billion (2020)

Want to see more? Sign up!